Smith, Moore & Co.
Source: SEC Form 13F · as of Mar 2026Smith, Moore & Co. holds 18 biotech & pharma companies tracked by BioSniper, totaling $31.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$31.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 29,261 | $6.4M |
| JNJJOHNSON & JOHNSON | 22,201 | $5.4M |
| LLYELI LILLY & Co | 5,672 | $5.2M |
| MRKMerck & Co., Inc. | 25,973 | $3.1M |
| ABTABBOTT LABORATORIES | 22,743 | $2.3M |
| AMGNAMGEN INC | 5,882 | $2.1M |
| PMPhilip Morris International Inc | 8,318 | $1.4M |
| ELVElevance Health Inc. | 3,896 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 16,276 | $987K |
| PFEPFIZER INC | 32,450 | $911K |
| RVMDREVOLUTION MEDICINES, INC. | 6,000 | $584K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,112 | $571K |
| MCKMcKesson Corporation | 395 | $342K |
| NVSNovartis AG | 1,870 | $286K |
| GILDGILEAD SCIENCES, INC. | 1,474 | $205K |
| GOSSGossamer Bio, Inc. | 470,000 | $154K |
| PGENPRECIGEN, INC. | 20,000 | $77K |
| ALTAltimmune, Inc. | 13,205 | $41K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.